The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B

被引：6
|
作者：
Shouval, Daniel [1 ]
机构：
[1] Hadassah Hebrew Univ Hosp, Liver Unit, IL-91120 Jerusalem, Israel
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 06期
关键词：
LACTIC-ACIDOSIS; NUCLEOSIDE; CIRRHOSIS; ANALOGS;
D O I：
10.1016/j.jhep.2014.03.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1108 / 1109
页数：2
相关论文
共 50 条
  • [21] Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis
    Ye, Xiao-Guang
    Su, Qi-Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (39) : 6665 - 6678
  • [22] ENTECAVIR RESISTANCE IN ENTECAVIR NAIVE LAMIVUDINE TREATED CHRONIC HEPATITIS B PATIENTS
    Sayan, Murat
    Hulagu, Sadettin
    Akhan, Sila Cetin
    Senturk, Omer
    Meric, Meliha
    Cekmen, Mustafa
    MIKROBIYOLOJI BULTENI, 2009, 43 (03): : 425 - 432
  • [23] Lamivudine vs. Entecavir for the newly diagnosed hepatitis B-virus related Hepatocellular carcinoma
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kim, Kyunga
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2015, 62 : 422A - 423A
  • [24] Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy
    Hung, Jeng-Hsiu
    Chu, Chi-Jen
    Sung, Pi-Lin
    Chen, Chih-Yao
    Chao, Kuan-Chong
    Yang, Ming-Jie
    Hung, Selena Chia-Yi
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2008, 71 (03) : 155 - 158
  • [25] Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir
    Son, Chang Young
    Ryu, Han Jak
    Lee, Jung Min
    Ahn, Sang Hoon
    Kim, Do Young
    Lee, Myoung Ha
    Han, Kwang Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    LIVER INTERNATIONAL, 2012, 32 (07) : 1179 - 1185
  • [26] Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study
    Tsubota, A
    Arase, Y
    Saitoh, S
    Kobayashi, M
    Suzuki, Y
    Suzuki, F
    Chayama, K
    Murashima, N
    Ikeda, K
    Kobayashi, M
    Kumada, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (02): : 557 - 562
  • [27] Entecavir monotherapy for lamivudine-refractory chronic hepatitis B
    Goulis, Ioannis
    Dalekos, George N.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (06) : 855 - 859
  • [28] Entecavir treatment is associated with increased short-term mortality in patients with severe acute exacerbation of chronic hepatitis B
    Wong, G. L. H.
    Wong, V. W. S.
    Chan, H. L. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A76 - A76
  • [29] Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B
    Bingliang Lin
    Calvin Q. Pan
    Dongying Xie
    Junqiang Xie
    Shibin Xie
    Xiaohong Zhang
    Biao Wu
    Chaoshuang Lin
    Zhiliang Gao
    Hepatology International, 2013, 7 : 460 - 467
  • [30] Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B
    Lin, Bingliang
    Pan, Calvin Q.
    Xie, Dongying
    Xie, Junqiang
    Xie, Shibin
    Zhang, Xiaohong
    Wu, Biao
    Lin, Chaoshuang
    Gao, Zhiliang
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 460 - 467
12345